早期胃癌内镜切除不完全时能否避免追加胃切除术
该单中心回顾性研究分析了2004年7月至2014年7月间350例内镜切除后行根治性胃切除加淋巴结清扫的胃癌患者,发现96例(27.4%)存在残留癌或淋巴结转移。多因素分析显示淋巴血管侵犯和浸润深度超过黏膜下层第二层是淋巴结转移的独立危险因素,而切缘阳性、浸润深度为黏膜或黏膜下层第一层及肿瘤大小超过3cm是胃残留肿瘤的显著危险因素。对于内镜切除时浸润深度为黏膜或黏膜下层第一层且无淋巴血管侵犯的不完全切除患者,可考虑追加内镜治疗或密切监测而非追加手术。
要点
- 淋巴血管侵犯和SM2浸润是淋巴结转移的独立危险因素。
- 切缘阳性、M/SM1浸润和肿瘤>3cm是胃残留肿瘤的危险因素。
- M/SM1浸润且无淋巴血管侵犯的不完全切除患者可考虑避免追加手术。
核心结论
- 对于内镜切除时浸润深度为黏膜或黏膜下层第一层且无淋巴血管侵犯的不完全切除早期胃癌患者,可考虑追加内镜治疗或密切监测替代追加手术,尤其适用于无法耐受胃切除术的老年或有合并症患者。
研究设计与样本
- 单中心回顾性分析2004年7月至2014年7月间350例内镜切除后行根治性胃切除加淋巴结清扫的胃癌患者,采用二元logistic多因素回归和分类回归树分析识别不完全切除的危险因素。
主要发现
- 96例(27.4%)患者残胃或淋巴结中发现残留癌细胞。
- 多因素分析显示淋巴血管侵犯(p < 0.001,OR 5.619)和浸润深度超过黏膜下层第二层(SM2)(p < 0.01,OR 3.224)是淋巴结转移的独立危险因素。
- 切缘阳性(p < 0.001,OR 7.565)、浸润深度为黏膜(M)和黏膜下层第一层(SM1)(p < 0.001,OR 4.219)及肿瘤大小超过3 cm(p < 0.029,OR 2.306)是残胃残留肿瘤的显著危险因素。
- 106例内镜切除时浸润深度为M或SM1且无淋巴血管侵犯的患者中,53例发现残留癌,其中50例(94.3%)残留癌位于黏膜层,仅1例有淋巴结转移。
临床怎么用
- 对于内镜切除时M或SM1浸润且无淋巴血管侵犯的不完全切除早期胃癌患者,可考虑追加内镜治疗或密切监测而非追加手术。
- 尤其适用于无法耐受胃切除术的患者,如老年或有合并症者。
局限性
- 本研究为单中心回顾性分析,样本量有限,结论需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endoscopic resection (ER) is a widely accepted treatment for patients with early gastric cancer (EGC) with no lymph node metastasis. Occasionally, however, additional surgery is needed due to an incomplete resection. The purpose of this study was to detect clinical factors which might identify patients at greater risk of additional surgery after ER and to suggest an alternative treatment strategy for these patients. METHODS: This study retrospectively analyzed 350 patients with gastric cancer who underwent radical gastrectomy and lymphadenectomy after ER in a single institution between July 2004 and July 2014. Risk factors for incomplete resection were identified using binary logistic multiple regression tests and a classification and regression tree analysis. RESULTS: Residual cancer cells were found in the remnant stomach or lymph node in 96 patients (27.4%). In multivariate analysis, lymphovascular invasion (p < 0.001, odds ratio [OR] 5.619) and depth of invasion greater than the second submucosal layer (SM2) (p < 0.01, OR 3.224) were independent risk factors for lymph node metastasis. Positive resection margin (p < 0.001, OR 7.565), depth of invasion to mucosa (M) and the first submucosal layer (SM1) (p < 0.001, OR 4.219), and size over 3 cm (p < 0.029, OR 2.306) were significant risk factors for residual tumor in the remnant stomach. Of 106 patients who had invasion of the M or SM1 without lymphatic invasion at the time of ER, residual cancer was found in 53 patients. Of these 53 patients, 50 (94.3%) had residual cancer in the mucosal layer and only one had lymph node metastasis. CONCLUSION: In patients with EGC with M or SM1 invasion without lymphovascular invasion at the time of ER, who had an incomplete resection, additional endoscopic treatment or close monitoring can be performed instead of additional surgery, especially in patients who are unable to tolerate gastrectomy, for example elderly patients or those with comorbidities.
引用
- Kim HS, Ahn JY, Kim SO, et al. Can further gastrectomy be avoided in patients with incomplete endoscopic resection? Surg Endosc. 2017. PMID: 28424913. doi:10.1007/s00464-017-5550-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。